Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin plus sulbactam 9 g/day versus 12 g/day for MDR Acinetobacter baumannii pneumonia
TCTR20210227001Phase 4Recruiting
- Sponsor
- Phramongkutklao Hospital
- Start
- Sep 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of colistin, sulbactam in Acinetobacter baumannii pneumonia, sponsored by Phramongkutklao Hospital. Started Sep 2019; status: recruiting.
02
Drugs
colistinsulbactam
03
Conditions
Acinetobacter baumannii pneumonia
Beyond the preview
Go deeper on TCTR20210227001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210227001.